Jim Simons’s iHuman IH Stock Holding History

Jim Simons’s Portfolio IH Stock Details IH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-11,125	Closed	-$34K	–	3892
2023 Q3	$34K	Sell	11,125 -3,735	-25%	-$11.5K	﹤0.01%	3456
2023 Q2	$44K	Buy	14,860 +2,160	+17%	+$6.69K	﹤0.01%	3639
2023 Q1	$41K	Buy	12,700 +200	+2%	+$644	﹤0.01%	3703
2022 Q4	$33K	Buy	+12,500	New	+$25.4K	﹤0.01%	3872
2021 Q4	–	Sell	-19,516	Closed	-$92K	–	4050
2021 Q3	$92K	Buy	+19,516	New	+$145K	﹤0.01%	3329

Other funds holding IH

APA

Arisaig Partners (Asia) Singapore $2.17M AUM 37.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Jim Simons's IH Position: Q4 2023 in Review

Jim Simons sold out of iHuman (IH) in Q4 2023, closing a stake of 11,125 shares — an estimated $34K sold.

Jim Simons first reported a position in IH in Q3 2021 and held it in 5 quarters. The position peaked at $92K in Q3 2021. 4 funds tracked by Wall St. Rank hold IH as of Q4 2023.

Jim Simons reported no remaining iHuman position as of Q4 2023 after selling out during the quarter.
Jim Simons sold 11,125 iHuman shares in Q4 2023, an estimated $34K.
Jim Simons first reported a position in iHuman in Q3 2021 and held it in 5 quarters.
Jim Simons's iHuman position peaked at $92K in Q3 2021.
4 funds tracked by Wall St. Rank held iHuman as of Q4 2023.

Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.